1682 related articles for article (PubMed ID: 30351060)
41. Doxorubicin-loaded polypeptide nanorods based on electrostatic interactions for cancer therapy.
Zhang L; Zhang P; Zhao Q; Zhang Y; Cao L; Luan Y
J Colloid Interface Sci; 2016 Feb; 464():126-36. PubMed ID: 26609932
[TBL] [Abstract][Full Text] [Related]
42. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
[TBL] [Abstract][Full Text] [Related]
43. Doxorubicin-loaded Fe
Cheng C; Li C; Zhu X; Han W; Li J; Lv Y
J Biomater Appl; 2019 May; 33(10):1373-1381. PubMed ID: 30880566
[TBL] [Abstract][Full Text] [Related]
44. Redox responsive liposomal nanohybrid cerasomes for intracellular drug delivery.
Zhou G; Li L; Xing J; Jalde S; Li Y; Cai J; Chen J; Liu P; Gu N; Ji M
Colloids Surf B Biointerfaces; 2016 Dec; 148():518-525. PubMed ID: 27690240
[TBL] [Abstract][Full Text] [Related]
45. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
Kashyap S; Singh N; Surnar B; Jayakannan M
Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
[TBL] [Abstract][Full Text] [Related]
46. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA
Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815
[No Abstract] [Full Text] [Related]
47. Ultra-thin metal-organic framework nanosheets for chemo-photodynamic synergistic therapy.
Zeng R; He T; Lu L; Li K; Luo Z; Cai K
J Mater Chem B; 2021 May; 9(20):4143-4153. PubMed ID: 33973611
[TBL] [Abstract][Full Text] [Related]
48. Fabrication of biocompatible magnetic maltose/MIL-88 metal-organic frameworks decorated with folic acid-chitosan for targeted and pH-responsive controlled release of doxorubicin.
Karimi S; Namazi H
Int J Pharm; 2023 Mar; 634():122675. PubMed ID: 36736967
[TBL] [Abstract][Full Text] [Related]
49. Synthesis, Formulation, and Characterization of Doxorubicin-Loaded Laponite/Oligomeric Hyaluronic Acid-Aminophenylboronic Acid Nanohybrids and Cytological Evaluation against MCF-7 Breast Cancer Cells.
Yang Y; Li J; Chen F; Qiao S; Li Y; Pan W
AAPS PharmSciTech; 2019 Nov; 21(1):5. PubMed ID: 31749020
[TBL] [Abstract][Full Text] [Related]
50. Increased Toxicity of Doxorubicin Encapsulated into pH-Responsive Poly(β-Amino Ester)-Functionalized MCM-41 Silica Nanoparticles.
Ávila-Ortega A; Carrillo-Cocom LM; Olán-Noverola CE; Nic-Can GI; Vilchis-Nestor AR; Talavera-Pech WA
Curr Drug Deliv; 2020; 17(9):799-805. PubMed ID: 32723272
[TBL] [Abstract][Full Text] [Related]
51. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
[TBL] [Abstract][Full Text] [Related]
52. Combined photothermal-chemotherapy of breast cancer by near infrared light responsive hyaluronic acid-decorated nanostructured lipid carriers.
Zheng S; Nguyen VD; Song SY; Han J; Park JO
Nanotechnology; 2017 Oct; 28(43):435102. PubMed ID: 28783035
[TBL] [Abstract][Full Text] [Related]
53. Metal-organic framework decorated with glycyrrhetinic acid conjugated chitosan as a pH-responsive nanocarrier for targeted drug delivery.
Cui L; Wang X; Liu Z; Li Z; Bai Z; Lin K; Yang J; Cui Y; Tian F
Int J Biol Macromol; 2023 Jun; 240():124370. PubMed ID: 37044320
[TBL] [Abstract][Full Text] [Related]
54. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
[TBL] [Abstract][Full Text] [Related]
55. Nanocarrier-Based Combination Chemotherapy for Resistant Tumor: Development, Characterization, and Ex Vivo Cytotoxicity Assessment.
Raikwar S; Vyas S; Sharma R; Mody N; Dubey S; Vyas SP
AAPS PharmSciTech; 2018 Nov; 19(8):3839-3849. PubMed ID: 30280350
[TBL] [Abstract][Full Text] [Related]
56. Stimuli-sensitive hollow spheres from chitosan-graft-β-cyclodextrin for controlled drug release.
Yu N; Li G; Gao Y; Liu X; Ma S
Int J Biol Macromol; 2016 Dec; 93(Pt A):971-977. PubMed ID: 27663551
[TBL] [Abstract][Full Text] [Related]
57. 2,2'-Dithiodisuccinic acid-stabilized polyion complex micelles for pH and reduction dual-responsive drug delivery.
Du Y; Yan W; Lian H; Xiang C; Duan L; Xiao C
J Colloid Interface Sci; 2018 Jul; 522():74-81. PubMed ID: 29579564
[TBL] [Abstract][Full Text] [Related]
58.
Zhu LB; Xu WL; Zhang WW; Wu MC; Li WZ; Ge F; Tao YG; Song P
Nanotechnology; 2021 Apr; 32(29):. PubMed ID: 33711826
[TBL] [Abstract][Full Text] [Related]
59. Conjugated Polymer Nanoparticles Based on Copper Coordination for Real-Time Monitoring of pH-Responsive Drug Delivery.
Li J; Du N; Tan Y; Hsu HY; Tan C; Jiang Y
ACS Appl Bio Mater; 2021 Mar; 4(3):2583-2590. PubMed ID: 35014375
[TBL] [Abstract][Full Text] [Related]
60. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
